Method for producing peptide, and method for processing bases
US-2020339623-A1 · Oct 29, 2020 · US
US11732002B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-11732002-B2 |
| Application number | US-201917297231-A |
| Country | US |
| Kind code | B2 |
| Filing date | Nov 29, 2019 |
| Priority date | Nov 30, 2018 |
| Publication date | Aug 22, 2023 |
| Grant date | Aug 22, 2023 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present inventors found that peptide compounds/amide compounds in which the protecting groups of interest are removed and/or which are removed from resins for solid-phase synthesis can be produced without main chain damage by contacting starting peptide compounds/amide compounds with silylating agents.
Opening claim text (preview).
The invention claimed is: 1. A method of producing a peptide compound in which a protecting group removable by a silylating agent is removed, the method comprising the step of contacting a starting peptide compound comprising natural amino acid residues and/or amino acid analog residues with the silylating agent in a solvent and thereby removing the protecting group from the starting peptide compound, wherein the silylating agent is prepared by: (i) mixing a silyl compound with an electrophilic species scavenger, or (ii) mixing an acid with a silyl-containing electrophilic species scavenger, wherein the starting peptide compound comprises at least one protecting group removable by the silylating agent, and wherein the starting peptide compound comprises at least one N-alkylated amino acid residue; wherein the electrophilic species scavenger in (i) has a formula selected from the group consisting of formulae (2) to (10) as defined below; and wherein the silyl-containing electrophilic species scavenger in (ii) is a compound having a formula selected from the group consisting of formulae (2)-(4), (6), (9), and (10) as defined below, provided that the compound has a silyl group: wherein in formula 2, R B is a substituted silyl group and R C is a substituted silyl group, or R B and R C , together with the nitrogen atom and oxygen atom to which they are attached, form a 5- to 7-membered ring; and R D is C 1 -C 4 alkyl optionally substituted with one or more fluorine atoms; wherein in formula 3, R G is a silyl group substituted with one or more C 1 -C 4 alkyl; R H is hydrogen or C 1 -C 4 alkyl; and R I is hydrogen, or C 1 -C 4 alkyl optionally substituted with one or more fluorine atoms; wherein in formula 4, (a-1) R J is a substituted silyl group, R K is C 1 -C 4 alkoxy, and R M and R L are independently hydrogen or C 1 -C 4 alkyl; (a-2) R J is a substituted silyl group, R M is hydrogen or C 1 -C 4 alkyl, and R K and R L , together with the carbon atoms to which they are attached, form a 5- to 8-membered ring comprising an oxygen atom; (b-1) R J is a substituted silyl group, R K is C 1 -C 4 alkyl, and R M and R L are independently hydrogen or C 1 -C 4 alkyl; (b-2) R J is a substituted silyl group, R M is hydrogen or C 1 -C 4 alkyl, and R K and R L together with the carbon atoms to which they are attached, form a 5- to 8-membered ring; or (c-1) R J and R M , together with the carbon atom and oxygen atom to which they are attached, form a 5- to 7-membered ring comprising an oxygen atom, R K is hydrogen or C 1 -C 4 alkyl, and R L is C 1 -C 4 alkyl; (c-2) R J and R M , together with the carbon atom and oxygen atom to which they are attached, form a 5- to 7-membered ring comprising an oxygen atom, and R K and R L , together with the carbon atom to which they are attached, form a 5- to 8-membered ring; (d-1) R J is C 1 -C 4 alkyl and R M , R K , and R L are independently hydrogen or C 1 -C 4 alkyl; (d-2) R J is C 1 -C 4 alkyl, R M is hydrogen or C 1 -C 4 alkyl, and R K and R L , together with the carbon atoms to which they are attached, form a 5- to 8-membered ring; (e-1) R J is C 1 -C 3 alkylcarbonyl and R M , R K , and R L are independently hydrogen or C 1 -C 4 alkyl; (e-2) R J is C 1 -C 3 alkylcarbonyl, R M is hydrogen or C 1 -C 4 alkyl, and R K and R L , together with the carbon atoms to which they are attached, form a 5- to 8-membered ring; (f-1) R J is a substituted silyl group or C 1 -C 4 alkyl, R K is optionally substituted di-C 1 -C 4 alkylamino, and R M and R L are independently hydrogen or C 1 -C 4 alkyl; or (f-2) R J is a substituted silyl group or C 1 -C 4 alkyl, R M is hydrogen or C 1 -C 4 alkyl, and R K and R L , together with the carbon atoms to which they are attached, form a 5- to 8-membered ring comprising a nitrogen atom, wherein the 5- to 8-membered ring is optionally substituted with C 1 -C 4 alkyl; wherein in formula 5, R N , R N′ , and R O are independently hydrogen or C 1 -C 4 alkyl; wherein in formula 6, R P is a substituted silyl group; and R Q is a substituted silyl group or C 1 -C 4 alkyl and R R is hydrogen, a substituted silyl group, or C 1 -C 4 alkyl, or R Q and R R , together with the nitrogen atom to which they are attached, form a 5- to 8-membered heterocyclic ring optionally comprising one or more additional heteroatoms; wherein in formula 7, X is a single bond or a carbon atom, wherein when X is a single bond, R S is absent, R UA and R RB , together with the carbon atom and nitrogen atom to which they are attached, form an optionally substituted 6-membered aromatic heterocyclic ring, and R UB and R T , together with the carbon atom and nitrogen atom to which they are attached, form an optionally substituted 6-membered aromatic heterocyclic ring, and when X is a carbon atom, R UA and R UB are independently C 1 -C 4 alkyl and R RB , R S , and R T , together with the carbon atoms to which they are attached, form the structure below: wherein in formula 8, R V is C 1 -C 4 alkyl or C 3 -C 6 cycloalkyl; wherein in formula 9, R W and R X are independently C 1 -C 4 alkyl or a substituted silyl group; and wherein in formula 10, R Y and R Z are independently C 1 -C 4 alkyl or a substituted silyl group. 2. A method of producing a peptide compound in which a resin for solid-phase synthesis that is removable by a silylating agent is removed, the method comprising the step of contacting a starting peptide compound comprising natural amino acid residues and/or amino acid analog residues with the silylating agent in a solvent and thereby removing the resin for solid-phase synthesis from the starting peptide compound, wherein the silylating agent is prepared by: (i) mixing a silyl compound with an electrophilic species scavenger, or (ii) mixing an acid with a silyl-containing electrophilic species scavenger, wherein the starting peptide compound is linked to the removable resin for solid-phase synthesis, and wherein the starting peptide compound comprises at least one N-substituted amino acid residue; wherein the electrophilic species scavenger in (i) has a formula selected from the group consisting of formulae (2) to (10) as defined below; and wherein the silyl-containing electrophilic species scavenger in (ii) is a compound having a formula selected from the group consisting of formulae (2)-(4), (6), (9), and (10) as defined below, provided that the compound has a silyl group: wherein in formula 2, R B is a substituted silyl group and R C is a substituted silyl group, or R B and R C , together with the nitrogen atom and oxygen atom to which they are attached, form a 5- to 7-membered ring; and R D is C 1 -C 4 alkyl optionally substituted with one or more fluorine atoms; wherein in formula 3, R G is a silyl group substituted with one or more C 1 -C 4 alkyl; R H is hydrogen or C 1 -C 4 alkyl; and R I is hydrogen, or C 1 -C 4 alkyl optionally substituted with one or more fluorine atoms; wherein in formula 4, (a-1) R J is a substituted silyl group, R K is C 1 -C 4 alkoxy, and R M and R L are independently hydrogen or C 1 -C 4 alkyl; (a-2) R J is a substituted silyl group, R M is hydrogen or C 1 -C 4 alkyl, and R K and R L , together with the carbon atoms to which they are attached, form a 5- to 8-membered ring comprising an oxygen atom; (b-1) R J is a substituted silyl
Fluorenes; Hydrogenated fluorenes · CPC title
from aliphatic carboxylic acids · CPC title
to carbon atoms of hydrocarbon radicals substituted by carboxyl groups · CPC title
on carriers {(C07K1/003, C07K1/006 take precedence)} · CPC title
using protecting groups or activating agents {(C07K1/003, C07K1/006 take precedence)} · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.